The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
COVID-19: Characteristics and Therapeutics
Open accessAbstract
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in December 2019 is still haunting the entire human race and has affected not only the healthcare system but also the global socioeconomic balances. COVID-19 was quickly designated as a global pandemic by the World Health Organization as there have been about 98.0 million confirmed cases and about 2.0 million confirmed deaths, as of January 2021. Although, our understanding of COVID-19 has significantly increased since its outbreak, and multiple treatment approaches and pharmacological interventions have been tested or are currently under development to mitigate its risk-factors. Recently, some vaccine candidates showed around 95% clinical efficacy, and now receiving emergency use approvals in different countries. US FDA recently approved BNT162 and mRNA-1273 vaccines developed by Pfizer/BioNTech and Moderna Inc. for emergency use and vaccination in the USA. In this review, we present a succinct overview of the SARS-CoV-2 virus structure, molecular mechanisms of infection, COVID-19 epidemiology, diagnosis, and clinical manifestations. We also systematize different treatment strategies and clinical trials initiated after the pandemic outbreak, based on viral infection and replication mechanisms. Additionally, we reviewed the novel pharmacological intervention approaches and vaccine development strategies against COVID-19. We speculate that the current pandemic emergency will trigger detailed studies of coronaviruses, their mechanism of infection, development of systematic drug repurposing approaches, and novel drug discoveries for current and future pandemic outbreaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Walsh, E. E., Frenck, R., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., et al. (2020) · doi:10.1101/2020.08.17.20176651 · Cited by 2,615
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
Coronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960
The COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., Chen, W., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25727 · Cited by 1,771
Diagnosing COVID-19: The Disease and Tools for Detection
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020) · ACS Nano · doi:10.1021/acsnano.0c02624 · Cited by 1,754
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China
Wang, W., Tang, J., & Wei, F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25689 · Cited by 1,480
Coronavirus disease 2019 (COVID-19): A literature review
Harapan, H., Itoh, N., Yufika, A., Winardi, W., Keam, S., Te, H., Megawati, D., Hayati, Z., Wagner, A. L., & Mudatsir, M. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.03.019 · Cited by 1,418
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31208-3 · Cited by 1,382
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
Ye, Z., Zhang, Y., Wang, Y., Huang, Z., & Song, B. (2020) · European Radiology · doi:10.1007/s00330-020-06801-0 · Cited by 1,349
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G., Liu, Y., et al. (2020) · Science · doi:10.1126/science.abd0826 · Cited by 1,303
Xia, S., Zhang, Y., Wang, Y., Wang, H., Yang, Y., Gao, G. F., Tan, W., Wu, G., Xu, M., Lou, Z., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30831-8 · Cited by 1,144
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066
Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31866-3 · Cited by 1,055
Assay Techniques and Test Development for COVID-19 Diagnosis
Carter, L. J., Garner, L. V., Smoot, J. W., Li, Y., Zhou, Q., Saveson, C. J., Sasso, J. M., Gregg, A. C., Soares, D. J., Beskid, T. R., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00501 · Cited by 985
SARS-CoV-2 (COVID-19) by the numbers
Bar-On, Y. M., Flamholz, A., Phillips, R., & Milo, R. (2020) · eLife · doi:10.7554/elife.57309 · Cited by 962
Genotype and phenotype of COVID-19: Their roles in pathogenesis
Mousavizadeh, L., & Ghasemi, S. (2021) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.022 · Cited by 962
Human Coronavirus: Host-Pathogen Interaction
Fung, T. S., & Liu, D. X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115759 · Cited by 960
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
Elfiky, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117592 · Cited by 923
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., Avanzato, V. A., Bushmaker, T., Flaxman, A., Ulaszewska, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2608-y · Cited by 914
COVID-19 Vaccine: A comprehensive status report
Kaur, S. P., & Gupta, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198114 · Cited by 852
Structure analysis of the receptor binding of 2019-nCoV
Chen, Y., Guo, Y., Pan, Y., & Zhao, Z. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.071 · Cited by 806
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Wu, D., & Yang, X. O. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.005 · Cited by 785
Wang, H., Zhang, Y., Huang, B., Deng, W., Quan, Y., Wang, W., Xu, W., Zhao, Y., Li, N., Zhang, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.008 · Cited by 748
Li, Y., Yao, L., Li, J., Chen, L., Song, Y., Cai, Z., & Yang, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25786 · Cited by 687
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 686
Setti, L., Passarini, F., De Gennaro, G., Barbieri, P., Perrone, M. G., Borelli, M., Palmisani, J., Di Gilio, A., Piscitelli, P., & Miani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082932 · Cited by 670
Advances in mRNA Vaccines for Infectious Diseases
Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 665
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2019) · Viruses · doi:10.3390/v11040326 · Cited by 622
Immunogenicity of a DNA vaccine candidate for COVID-19
Smith, T. R. F., Patel, A., Ramos, S., Elwood, D., Zhu, X., Yan, J., Gary, E. N., Walker, S. N., Schultheis, K., Purwar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16505-0 · Cited by 601
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
Cheng, M. P., Papenburg, J., Desjardins, M., Kanjilal, S., Quach, C., Libman, M., Dittrich, S., & Yansouni, C. P. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1301 · Cited by 593
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138996 · Cited by 575
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Shiraki, K., & Daikoku, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107512 · Cited by 573
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 572
Evolution of the COVID-19 vaccine development landscape
Le, T. T., Cramer, J. P., Chen, R., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00151-8 · Cited by 556
A systematic review of SARS-CoV-2 vaccine candidates
Dong, Y., Dai, T., Wei, Y., Zhang, L., Zheng, M., & Zhou, F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00352-y · Cited by 545
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200516 · Cited by 542
Pruijssers, A. J., George, A. S., Schäfer, A., Leist, S. R., Gralinksi, L. E., Dinnon, K. H., Yount, B. L., Agostini, M. L., Stevens, L. J., Chappell, J. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107940 · Cited by 510
Drug repurposing approach to fight COVID-19
Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00155-6 · Cited by 480
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 475
Why tocilizumab could be an effective treatment for severe COVID-19?
Fu, B., Xu, X., & Wei, H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02339-3 · Cited by 445
The type I interferon response in COVID-19: implications for treatment
Lee, J. S., & Shin, E.-C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00429-3 · Cited by 421
Interferon-α2b Treatment for COVID-19
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01061 · Cited by 417
The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020) · Journal of Virology · doi:10.1128/jvi.00647-20 · Cited by 410
COVID-19 diagnostics in context
Weissleder, R., Lee, H., Ko, J., & Pittet, M. J. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc1931 · Cited by 396
Favipiravir: A new and emerging antiviral option in COVID-19
Agrawal, U., Raju, R., & Udwadia, Z. F. (2020) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2020.08.004 · Cited by 390
Next-generation vaccine platforms for COVID-19
van Riel, D., & de Wit, E. (2020) · Nature Materials · doi:10.1038/s41563-020-0746-0 · Cited by 374
mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
Xu, S., Yang, K., Li, R., & Zhang, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186582 · Cited by 368
Antiviral treatment of COVID-19
ŞİMŞEK YAVUZ, S., & ÜNAL, S. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-145 · Cited by 367
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19
Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y., & Zhu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25798 · Cited by 359
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19
Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., & Kiyotani, K. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0808-9 · Cited by 348
Immune-mediated approaches against COVID-19
Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi-Fainaro, R. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0732-3 · Cited by 338
Shannon, A., Selisko, B., Le, N.-T.-T., Huchting, J., Touret, F., Piorkowski, G., Fattorini, V., Ferron, F., Decroly, E., Meier, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18463-z · Cited by 296
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
Mittal, A., Manjunath, K., Ranjan, R. K., Kaushik, S., Kumar, S., & Verma, V. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008762 · Cited by 290
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden
Keni, R., Alexander, A., Nayak, P. G., Mudgal, J., & Nandakumar, K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00216 · Cited by 272
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Lin, M.-H., Moses, D. C., Hsieh, C.-H., Cheng, S.-C., Chen, Y.-H., Sun, C.-Y., & Chou, C.-Y. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.015 · Cited by 250
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Zhang, X., Song, K., Tong, F., Fei, M., Guo, H., Lu, Z., Wang, J., & Zheng, C. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001907 · Cited by 248
Understanding Antibody Testing for COVID-19
Jacofsky, D., Jacofsky, E. M., & Jacofsky, M. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.04.055 · Cited by 248
Vankadari, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105998 · Cited by 247
Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
Gussow, A. B., Auslander, N., Faure, G., Wolf, Y. I., Zhang, F., & Koonin, E. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008176117 · Cited by 247
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., Avanzato, V., Bushmaker, T., Flaxman, A., Ulaszewska, M., et al. (2020) · doi:10.1101/2020.05.13.093195 · Cited by 246
An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Wang, F., Kream, R. M., & Stefano, G. B. (2020) · Medical Science Monitor · doi:10.12659/msm.924700 · Cited by 243
Azithromycin in the treatment of COVID-19: a review
Echeverría-Esnal, D., Martin-Ontiyuelo, C., Navarrete-Rouco, M. E., De-Antonio Cuscó, M., Ferrández, O., Horcajada, J. P., & Grau, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1813024 · Cited by 242
Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2
Rehman, S. U., Shafique, L., Ihsan, A., & Liu, Q. (2020) · Pathogens · doi:10.3390/pathogens9030240 · Cited by 237
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19
Jorgensen, S. C. J., Tse, C. L. Y., Burry, L., & Dresser, L. D. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2438 · Cited by 225
Cheng, R. Z. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100028 · Cited by 219
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Funk, C. D., Laferrière, C., & Ardakani, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00937 · Cited by 201
Recent Advances in Vaccine Technologies
Francis, M. J. (2018) · Veterinary Clinics of North America: Small Animal Practice · doi:10.1016/j.cvsm.2017.10.002 · Cited by 199
Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
Kilic, T., Weissleder, R., & Lee, H. (2020) · iScience · doi:10.1016/j.isci.2020.101406 · Cited by 196
Zhang, X., Zhang, Y., Qiao, W., Zhang, J., & Qi, Z. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106749 · Cited by 182
Wu, J., Li, J., Zhu, G., Zhang, Y., Bi, Z., Yu, Y., Huang, B., Fu, S., Tan, Y., Sun, J., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04160320 · Cited by 181
Fintelman-Rodrigues, N., Sacramento, C. Q., Ribeiro Lima, C., Souza da Silva, F., Ferreira, A. C., Mattos, M., de Freitas, C. S., Cardoso Soares, V., da Silva Gomes Dias, S., Temerozo, J. R., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-20 · Cited by 179
Taylor, R., Kotian, P., Warren, T., Panchal, R., Bavari, S., Julander, J., Dobo, S., Rose, A., El-Kattan, Y., Taubenheim, B., et al. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.04.002 · Cited by 177
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
Liu, Y., Liang, C., Xin, L., Ren, X., Tian, L., Ju, X., Li, H., Wang, Y., Zhao, Q., Liu, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112711 · Cited by 170
New Therapies for Hepatitis C Virus Infection
Soriano, V., Peters, M. G., & Zeuzem, S. (2009) · Clinical Infectious Diseases · doi:10.1086/595848 · Cited by 168
Exploring links between vitamin D deficiency and COVID-19
Mohan, M., Cherian, J. J., & Sharma, A. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008874 · Cited by 164
Zhang, L., & Zhou, R. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c04198 · Cited by 163
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Ita, K. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.010 · Cited by 163
Musarrat, F., Chouljenko, V. N., Dahal, A., Nabi, R., Chouljenko, T., Jois, S. D. S., & Kousoulas, K. G. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25985 · Cited by 162
Colchicine in COVID-19: an Old Drug, New Use
Schlesinger, N., Firestein, B. L., & Brunetti, L. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00225-6 · Cited by 150
Uzunova, K. H., Filipova, E. P., Pavlova, V., & Vekov, T. Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110668 · Cited by 144
Nițulescu, G. M., Păunescu, H., Moschos, S. A., Petrakis, D., Nițulescu, G., Ion, D., Spandidos, D. A., Νikolouzakis, Τ. Κ., Drakoulis, N., & Tsatsakis, A. M. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4608 · Cited by 141
Bray, M., Rayner, C. R., Noël, F., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104805 · Cited by 138
Mercurio, I., Tragni, V., Busto, F., Grassi, A., & Pierri, C. L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03580-1 · Cited by 137
White, N. J., Watson, J. A., Hoglund, R. M., Chan, X. H. S., Cheah, P. Y., & Tärning, J. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003252 · Cited by 131
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
Li, H., Liu, Z., & Ge, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15364 · Cited by 127
Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19
Chen, J., Xia, L., Liu, L., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa241 · Cited by 124
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
Lei, Z., Wu, Z., Dong, S., Yang, D., Zhang, L., Ke, Z., Zou, C., & Chen, Z. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107672 · Cited by 119
Potential Treatments for COVID-19; a Narrative Literature Review.
Rismanbaf, A. (2020) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v8i1.596 · Cited by 118
Faustini, S. E., Jossi, S. E., Pérez-Toledo, M., Shields, A. M., Allen, J. D., Watanabe, Y., Newby, M. L., Cook, A. M., Willcox, C. R., Salim, M., et al. (2021) · Immunology · doi:10.1111/imm.13349 · Cited by 118
Imai, K., Tabata, S., Ikeda, M., Noguchi, S., Kitagawa, Y., Matuoka, M., Miyoshi, K., Tarumoto, N., Sakai, J., Ito, T., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104393 · Cited by 116
Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
Feyaerts, A. F., & Luyten, W. H. M. L. (2020) · Nutrition · doi:10.1016/j.nut.2020.110948 · Cited by 111
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
Shih, H., Wu, C.-J., Tu, Y., & Chi, C. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.021 · Cited by 109
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
Satarker, S., Ahuja, T. N., Banerjee, M., Vignesh Balaji, E., Dogra, S. S., Agarwal, T., & Nampoothiri, M. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00231-8 · Cited by 106
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
Yamamoto, V., Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200831 · Cited by 100
Pirfenidone: A novel hypothetical treatment for COVID-19
Seifirad, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110005 · Cited by 99
Broad-spectrum antiviral agents
Zhu, J., Meng, W., Wang, X.-J., & Wang, H. R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00517 · Cited by 94
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention
Mahmoud, I. S., Jarrar, Y. B., Alshaer, W., & Ismail, S. I. (2020) · Biochimie · doi:10.1016/j.biochi.2020.05.012 · Cited by 90
Planning for COVID-19 vaccines safety surveillance
Kochhar, S., & Salmon, D. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.013 · Cited by 87
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
Sullivan, H. C., & Roback, J. D. (2020) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2020.04.001 · Cited by 85
What Do We Know About Remdesivir Drug Interactions?
Yang, K. Y. (2020) · Clinical and Translational Science · doi:10.1111/cts.12815 · Cited by 85
Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR: reflecting on experience from MERS-CoV
Al‐Tawfiq, J. A., & Memish, Z. A. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.03.001 · Cited by 83
Masiá, M., Fernández‐González, M., Padilla, S., Ortega, P., García, J. A., Agulló, V., García‐Abellán, J., Telenti, G., Guillén, L., & Gutiérrez, F. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102999 · Cited by 81
Patel, A. R., Walters, J. N., Reuschel, E. L., Schultheis, K., Parzych, E. M., Gary, E. N., Maricic, I., Purwar, M., Eblimit, Z., Walker, S. N., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100420 · Cited by 80
Augustine, R., Das, S., Hasan, A., Abhilash, S., Salam, S. A., Augustine, P., Dalvi, Y. B., Varghese, R., Primavera, R., Yassine, H. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103372 · Cited by 79
A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
Hossen, M. S., Barek, M. A., Jahan, N., & Islam, M. S. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00485-9 · Cited by 75
Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm
Wiemer, A. J. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00076 · Cited by 70
Patel, A. R., Walters, J. N., Reuschel, E., Schultheis, K., Parzych, E. M., Gary, E., Maričić, I., Purwar, M., Eblimit, Z., Walker, S. N., et al. (2020) · bioRxiv · doi:10.1101/2020.07.28.225649 · Cited by 62
Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond
Ekins, S., Lane, T. R., & Madrid, P. B. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02799-8 · Cited by 60
Advances in the possible treatment of COVID-19: A review.
Chibber, P., Haq, S. A., Ahmed, I., Andrabi, N. I., & Singh, G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173372 · Cited by 60
Vaccine Against Covid-19 Disease – Present Status of Development
Dutta, A. K. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03475-w · Cited by 58
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study
Pereira, M. R., Aversa, M. M., FARR, M. A., Miko, B. A., Aaron, J. G., Mohan, S., Cohen, D. J., Husain, S. A., Ratner, L. E., Arcasoy, S. M., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16314 · Cited by 57
Prazuck, T., Colin, M., Giachè, S., Gubavu, C., Sève, A., Rzepecki, V., Chevereau-Choquet, M., Kiani, C., Rodot, V., Lionnet, E., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237694 · Cited by 56
Vitamin C as a Possible Therapy for COVID-19
Hemilä, H., & Chalker, E. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.2.222 · Cited by 54
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
Dastan, F., Saffaei, A., Haseli, S., Marjani, M., Moniri, A., Abtahian, Z., Abedini, A., Kiani, A., Seifi, S., Jamaati, H., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106869 · Cited by 54
Clinical Samples for SARS-CoV-2 Detection: Review of the Early Literature
Martinez, R. M. (2020) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2020.07.001 · Cited by 52
Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects
Vyas, N., Kurian, S. J., Bagchi, D., Manu, M. K., Saravu, K., Unnikrishnan, M. K., Mukhopadhyay, C., Rao, M., & Miraj, S. S. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2020.1806758 · Cited by 51
A comprehensive review on potential therapeutics interventions for COVID-19
Chugh, H., Awasthi, A., Agarwal, Y., Gaur, R. K., Dhawan, G., & Chandra, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173741 · Cited by 51
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
Lane, T. R., Massey, C., Comer, J. E., Anantpadma, M., Freundlich, J. S., Davey, R. A., Madrid, P. B., & Ekins, S. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007890 · Cited by 49
Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis
Bewersdorf, J. P., Jaszczur, S. M., Afifi, S., Zhao, J. C., & Zeidan, A. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s212559 · Cited by 46
Vitamin C for COVID-19: A living systematic review
Baladía, E., Pizarro, A. B., Ortiz-Muñoz, L. E., & Gabriel Rada, G. (2020) · Medwave · doi:10.5867/medwave.2020.06.7978 · Cited by 46
Vitamin D and Covid‐19: From potential therapeutic effects to unanswered questions
Teymoori‐Rad, M., & Marashi, S. M. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2159 · Cited by 46
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)
Bennet, B. M., Wolf, J. J., Laureano, R., & Sellers, R. S. (2020) · Toxicologic Pathology · doi:10.1177/0192623320959090 · Cited by 45
Convalescent plasma therapy in patients with COVID ‐19
Yiğenoğlu, T. N., Hacıbekiroğlu, T., Berber, İ., Dal, M. S., Baştürk, A., Namdaroğlu, S., Korkmaz, S., Ulaş, T., Dal, T., Erkurt, M. A., et al. (2020) · Journal of Clinical Apheresis · doi:10.1002/jca.21806 · Cited by 43
The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection
Acosta‐Elías, J., & Espinosa‐Tanguma, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01062 · Cited by 43
Sanders, W., Fritch, E. J., Madden, E. A., Graham, R. L., Vincent, H. A., Heise, M. T., Baric, R. S., & Moorman, N. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.15.153197 · Cited by 42
Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition
Ye, W., Yao, M., Dong, Y., Ye, C., Wang, D., Liu, H., Ma, H., Zhang, H., Qi, L., Yang, Y., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01105 · Cited by 42
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
Sánchez‐Pernaute, O., Romero-Bueno, F., & Selva-O’Callaghan, A. (2020) · Reumatología Clínica · doi:10.1016/j.reuma.2020.03.001 · Cited by 40
Mollaei, H. R., Afshar, A. A., Kalantar-Neyestanaki, D., Fazlalipour, M., & Aflatoonian, B. (2020) · Iranian Journal of Microbiology · doi:10.18502/ijm.v12i3.3234 · Cited by 40
von Essen, M. R., Søndergaard, H. B., Petersen, E. R., & Sellebjerg, F. T. (2019) · Cells · doi:10.3390/cells8030285 · Cited by 37
Potential inhibitors for the novel coronavirus (SARS-CoV-2)
Han, Y., Wang, Z., Ren, J., Wei, Z., & Li, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa209 · Cited by 33
Shyu, D., Dorroh, J., Holtmeyer, C., Ritter, D. G., Upendran, A., Kannan, R., Dandachi, D., Rojas‐Moreno, C., Whitt, S. P., & Regunath, H. (2020) · PubMed · Cited by 32
Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00310-8 · Cited by 31
New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
Gupta, P. K. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104187 · Cited by 30
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update
Pal, A., Pawar, A. T., Goswami, K., Sharma, P., & Prasad, R. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00900-x · Cited by 27
Baricitinib: A chance to treat COVID‐19?
Caputo, S. L., Corso, G., Clerici, M., & Santantonio, T. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26033 · Cited by 25
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
Offerhaus, J. A., Wilde, A. A. M., & Remme, C. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.07.001 · Cited by 22
Zang, Y., Han, X., He, M., Shi, J. C., & Li, Y. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01964-5 · Cited by 17
The effect of antivirals on COVID-19: a systematic review
Hussain, N., Yoganathan, A., Hewage, S., Alom, S., & Harky, A. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1823832 · Cited by 14
Atypical presentation of SARS-CoV-2 infection: A case report
Li, R., Chu, S., Luo, Y., Huang, Z., Hao, Y., & Fan, C. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i7.1265 · Cited by 10
Tocilizumab for severe COVID-19 pneumonia
Lipworth, B. J., Chan, R., & Kuo, C. R. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30283-6 · Cited by 5
Could azithromycin play a role in the treatment of COVID-19? A reviewPreprint
Echeverría-Esnal, D., Martín‐Ontiyuelo, C., Rouco, M. E. N., Antonio, M. D., Ferrández, O., Horcajada, J. P., & Grau, S. (2020) · doi:10.22541/au.159170711.16292378 · Cited by 3
Antiviral therapy for coronavirus disease 2019.
Gong, S., Su, J. Y., Yan, X., Li, F., Hu, L., & Liu, S. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.200211 · Cited by 1
Cited by
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 281
Myocarditis following COVID-19 mRNA vaccination
Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., Zoabi, M., Aisman, M., Goldschmid, N., & Berar Yanay, N. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.087 · Cited by 274
Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Mansanguan, S., Charunwatthana, P., Piyaphanee, W., Dechkhajorn, W., Poolcharoen, A., & Mansanguan, C. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080196 · Cited by 83
Metadata
- Authors
- Chilamakuri, R., & Agarwal, S.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-01-21
- Volume
- 10
- Issue
- 2
- Pages
- 206
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3124895527
- Cited by
- 282
- References
- 171
- FWCI
- 17.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.